Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis

Conditions: Plaque Psoriasis Interventions: Drug: D-2570; Drug: Placebo Sponsors: InventisBio Co., Ltd Recruiting

Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials